Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05689294 · ClinicalTrials.gov registry record

Non Invasive Continuous Blood Pressure Sensor

A clinical trial of Blood Pressure and Anesthesia, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
15
Enrollment target
1
Study location

NCT05689294: Completed study of Blood Pressure and Anesthesia, sponsored by Dartmouth-Hitchcock Medical Center.

NCT05689294 is a study of Blood Pressure and Anesthesia that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 15 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05689294, a study of Blood Pressure and Anesthesia, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to collect training data in order to establish a method for correlating arterial blood pressure with voltage output signals from a non-invasive piezoelectric array sensor placed on the skin superficial to the radial artery.

Primary Outcome

We will be capturing arterial blood pressure measurement per standard of care from arterial line. This will include systolic and diastolic measurements and will be sampled continuously from standard invasive monitoring equipment. Because of the high frequency sampling, we will be capturing the entire pulse waveform with each heartbeat.

Study Locations (1)

New Hampshire

  • Dartmouth Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-04-01
Est. Completion 2023-10-30
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT05689294 record still lists

NCT05689294 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 0 interventions.

NCT05689294 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05689294 about?

NCT05689294 is a clinical study titled "Non Invasive Continuous Blood Pressure Sensor". The primary objective of this study is to collect training data in order to establish a method for correlating arterial blood pressure with voltage output signals from a non-invasive piezoelectric array sensor placed on the skin superficial to the radial artery.

What is the current status of trial NCT05689294?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2023-04-01. Estimated completion is 2023-10-30.

What conditions does trial NCT05689294 study?

This clinical trial studies the following conditions: Blood Pressure, Anesthesia, Arterial Line.

Who is sponsoring clinical trial NCT05689294?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05689294 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05689294's enrollment target sits among peer trials

15 92nd of 101 higher than 8 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05689294, the US trial registry maintained by the National Library of Medicine. NCT05689294 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.